Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.77% inched 0.42% higher to $178.82 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.16% rising 2.02% to 4,088.85 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.42% rising 1.34% to 32,654.59. This was the stock's second consecutive day of gains. Johnson & Johnson closed $7.87 short of its 52-week high ($186.69), which the company achieved on April 25th.
The stock underperformed when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -1.25% rose 2.26% to $322.62, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.24% rose 0.74% to $93.00, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -1.28% rose 1.32% to $51.34. Trading volume (5.7 M) remained 2.0 million below its 50-day average volume of 7.8 M.